Showing results (151-160 of 168) with videos related to
Sort By:
Pageof 17
Cell Reports Methods|April 14, 2023
Phenotypic deconvolution in heterogeneous cancer cell populations using drug-screening dataAlvaro Köhn-Luque, Even Moa Myklebust, Dagim Shiferaw Tadele, et al.Nature Reviews Bioengineering|February 20, 2026
Synthetic living materials in cancer biologyShelly R Peyton, Lesley W Chow, Stacey D Finley, et al.Biorxiv : the Preprint Server for Biology|May 15, 2024
Targeting circadian transcriptional programs through a cis-regulatory mechanism in triple negative breast cancerYuanzhong Pan, Tsu-Pei Chiu, Lili Zhou, et al.Oncogene|October 1, 2022
Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatmentFrancesca Battaglin, Priya Jayachandran, Carly Strelez, et al.Biorxiv : the Preprint Server for Biology|September 25, 2023
Integration of Patient-Derived Organoids and Organ-on-Chip Systems: Investigating Colorectal Cancer Invasion within the Mechanical and GABAergic Tumor MicroenvironmentCarly Strelez, Rachel Perez, John S Chlystek, et al.Journal for Immunotherapy of Cancer|November 11, 2020
Immunogenic cell death pathway polymorphisms for predicting oxaliplatin efficacy in metastatic colorectal cancerHiroyuki Arai, Yi Xiao, Fotios Loupakis, et al.Plos One|June 11, 2015
Predictive Modeling of Drug Response in Non-Hodgkin's LymphomaHermann B Frieboes, Bryan R Smith, Zhihui Wang, et al.Molecular Cancer Therapeutics|March 31, 2021
RNA-Binding Protein Polymorphisms as Novel Biomarkers to Predict Outcomes of Metastatic Colorectal Cancer: A Meta-analysis from TRIBE, FIRE-3, and MAVERICCHiroyuki Arai, Shu Cao, Francesca Battaglin, et al.Oncogene|January 17, 2023
Breast cancer and neurotransmitters: emerging insights on mechanisms and therapeutic directionsPriya Jayachandran, Francesca Battaglin, Carly Strelez, et al.European Journal of Cancer (Oxford, England : 1990)|March 11, 2019
Impact of polymorphisms within genes involved in regulating DNA methylation in patients with metastatic colorectal cancer enrolled in three independent, randomised, open-label clinical trials: a meta-analysis from TRIBE, MAVERICC and FIRE-3Alberto Puccini, Fotios Loupakis, Sebastian Stintzing, et al.Pageof 17